Purchase Order HHSN276201100246P
Award Date
3/1/11
Potential Completion Date
2/29/12
Potential Value
$9.5K
Funding Federal Agency
National Institute of Diabetes and Digestive and Kidney Diseases
Contracting Federal Agency
National Institute of Environmental Health Sciences
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Phoenix, AZ 85016, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. The contract, valued at $80,449.94, is for the provision of Illumina's sequencing and analytical instruments and reagents to support NIDDK's genomic research and diagnostics efforts. The contract has no set-aside designation. Illumina has previously been awarded prime...
This is a $5,216.64 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. for the provision of sequencing systems, reagents, and related services. The award has no set-aside designation. Illumina, a for-profit manufacturer, has previously supported genomic sequencing and analysis efforts across various federal agencies including the NIH, CDC, USDA,...
This is a firm fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS), to Illumina, Inc. The contract, valued at $72,422.58, is for the provision of Illumina's sequencing instruments, reagents, and related products and services to support NIDDK's genomic research and analysis needs. Illumina has previously served as a prime contractor and...
This is a firm fixed price delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The contract has a ceiling value of $100,502.64 and a completion date of September 2, 2020. Illumina has provided various sequencing systems, reagents, consumables, and bioinformatics products to support genomic research and diagnostics for NIDDK...
This is a firm fixed price delivery order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $97,054.04 contract does not have a set-aside designation. Based on Illumina's history of supporting genomic research and diagnostics across federal agencies, this award is likely for the provision of Illumina's sequencing systems, consumables, and...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract, valued at $12,875.00, is for sequencing services to support NIAID's research and diagnostic efforts. Illumina has previously been awarded other prime federal contracts and subcontracts by...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Illumina, Inc. The $292,500.00 contract is for the provision of Illumina sequencing systems, reagents, and associated products and services to support genomic sequencing and analysis. Illumina is an experienced provider of sequencing and genomic analysis technologies to federal agencies, having previously supported work at the NIH, Centers for...
This firm fixed-price purchase order for $50,445.50 was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency of the U.S. government, to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the delivery of reagent kits and has a completion date of September 29, 2023. The contract was competitively awarded with no set-aside designation. Illumina has previously provided...
This is a federal contract award to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The award, valued at $10,331.78, is a delivery order placed under a larger federal contract vehicle. The award is for Illumina to provide sequencing systems, reagents, and related services to support genomic sequencing and analysis for the National Human Genome Research Institute, which is part of the National Institutes of Health (NIH), a civilian agency. The...
This is a firm fixed price delivery order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. The $103,374.14 contract is for the provision of Illumina's sequencing systems, reagents, and related services to support genomic sequencing and analysis for research and diagnostic purposes. The contract has no set-aside designation. Illumina has previously been awarded prime...